Process technology developments are at the heart of any efforts to increase the productivity and robustness of biopharmaceutical manufacturing
This Process Technologies Roadmap is intended to guide industry participants towards better technological solutions in their manufacturing plants mid to long term, thus enabling expanded patient access to safe and cost-effective biopharmaceutical medicine while maintaining the viability of an R&D-driven drug development.
This first edition of this roadmap places special emphasis on technologies that have the greatest probability of success for implementation in a manufacturing setting within a 10-year time horizon. The document focuses on the most common production scenarios in the industry, namely on 2,000L disposable and 10,000L (and larger) stainless steel (SS) bioreactor capacities for the commercial production of monoclonal antibodies (mAbs).
This is 1 of 8 roadmap documents, to download others click on the ‘First Edition Documents’ menu